Nanoengineered injectable hydrogels derived from layered double hydroxides and alginate for sustained release of protein therapeutics in tissue engineering applications

Chronic Kidney Disease (CKD) which involves gradual loss of kidney function is characterized by low levels of a glycoprotein called Erythropoietin (EPO) that leads to red blood cell  deficiency and anemia. Recombinant human EPO (rhEPO) injections that are administered intravenously or subcutaneously...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, V. H. Giang, Duong, Hai-Sang, Le, Quynh-Giao Thi, Janarthanan, Gopinathan, Vijayavenkataraman, Sanjairaj, Nguyen, Hoang-Nam Huynh, Nguyen, Bich-Phuong Thi, Manivasagan, Panchanathan, Jang, Eue-Soon, Li, Yi, Thambi, Thavasyappan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623704/
https://www.ncbi.nlm.nih.gov/pubmed/37919778
http://dx.doi.org/10.1186/s12951-023-02160-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623704/
https://www.ncbi.nlm.nih.gov/pubmed/37919778
http://dx.doi.org/10.1186/s12951-023-02160-2

Ejemplares similares